Phibro Animal Health | PAHC - Ebitda


Phibro Animal Health reported $68.1M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Align Technology USD 232.86M 3.72M Jun/2026
ANI Pharmaceuticals USD 83.3M 11.7M Sep/2026
Aurora Cannabis CAD 799K 2.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Canopy Growth CAD 8M 145M Jun/2026
Corcept Therapeutics USD 115.75M 73.59M Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Henry Schein USD 321M 33M Sep/2026
Idexx Laboratories USD 447.35M 21.11M Sep/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Merck USD 1.42B 2.97B Jun/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Pacira USD 50.45M 1.78M Sep/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 89.44M 28.2M Sep/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026
Zoetis USD 1.07B 21M Sep/2026